Collectively, these results suggest that CLU is able to bind ROCK1 to block the ROCK1/ERK axis and inactivates ERK1/2 activity, leading to the potent suppression of migration, invasion and metastasis in lung cancer (Figure 6H). The gene discussed is MAPK3; the disease is lung cancer.